900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Cancer cervix - screening done	Screening for malignant neoplasm of cervix done (situation)
Candida famata	Debaryomyces hansenii
Candida famata	Debaryomyces hansenii
Candida guilliermondii, Variante guilliermondii	Meyerozyma guilliermondii (organism)
Candida humicola	Vanrija humicola (organism)
Candida krusei var. vanlaeriana	Pichia membranifaciens (organism)
Candida lipolytica	Yarrowia lipolytica
Candida pseudotropicalis	Kluyveromyces marxianus
Candidiasis of other specified sites	Candidiasis
Candidiasis of other urogenital sites	Candidiasis of urogenital site
Canine cortical hyperostosis	Disorder of bone (disorder)
Canis familiaris	Canis lupus subspecies familiaris (organism)
Canis rufus	Canis lupus subspecies rufus (organism)
Cannabinoid	Cannabis (substance)
Cannabinoid - non-pharmaceutical	Cannabis (substance)
Cannabis dependence with current use	Cannabis dependence
cannabis non pharmaceutique	Cannabis (substance)
feuilles de cannabis non pharmaceutiques	Cannabis leaf (substance)
huile de cannabis non pharmaceutique	Cannabis oil (substance)
résine de cannabis non pharmaceutique	Cannabis resin (substance)
Cannulation - action	Insertion - action (qualifier value)
Capillary hemangioma - category	Capillary hemangioma
Capnocytophaga canimorsus	Capnocytophaga canimorsus
Caprine adenovirus	Goat adenovirus (organism)
Capsaicin 179mg/hour transdermal patch	Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug)
Capsule of distal interphalangeal joint of great toe	Structure of capsule of interphalangeal joint of great toe
Captopril allergy	Non-allergic hypersensitivity to captopril (finding)
Carbachol 1% eye drops	Product containing precisely carbachol 10 milligram/1 milliliter conventional release eye solution (clinical drug)
Carbachol 1.5% eye drops	Carbachol 15 mg/mL eye solution
Carbachol 1.5% solution	Carbachol 15 mg/mL eye solution
Carbachol 250micrograms/mL intraocular injection solution 1mL ampule	Product containing precisely carbachol 250 microgram/1 milliliter conventional release solution for injection (clinical drug)
Carbamazepine 100mg m/r capsule	Carbamazepine only product in oral dose form
Carbamazepine 100mg m/r tablet	Carbamazepine only product in oral dose form
Carbamazepine 100mg prolonged-release oral capsule	Carbamazepine only product in oral dose form
Carbamazepine 100mg prolonged-release oral tablet	Carbamazepine only product in oral dose form
Carbamazepine 200mg m/r capsule	Carbamazepine only product in oral dose form
Carbamazepine 200mg prolonged-release oral capsule	Carbamazepine only product in oral dose form
Carbamazepine 300mg m/r capsule	Carbamazepine only product in oral dose form
Carbamazepine 300mg prolonged-release oral capsule	Carbamazepine only product in oral dose form
Carbenoxolone sodium 1% mouthwash granules	Carbenoxolone only product
Carbenoxolone sodium 2% oral gel	Carbenoxolone 20 mg/g oromucosal gel
Carbidopa + levodopa 25mg/100mg m/r tablet	Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet
Carbidopa + levodopa 50mg/200mg m/r tablet	Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Carbidopa 10mg/levodopa 100mg orally disintegrating tablet	Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet	Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet
Carbidopa 25mg	Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)
Carbidopa 25mg/levodopa 100mg orally disintegrating tablet	Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 25mg/levodopa 250mg orally disintegrating tablet	Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet	Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop	Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup	Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup	Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops	Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet	Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet	Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbohydrate agent	Carbohydrate
Carbol fuchsin stain	Carbol-fuchsin (substance)
Carbon-carbon lyase	Carbon-carbon lyase
Carbon-halide lyase	Carbon-halide lyase
Carbon-nitrogen lyase	Carbon-nitrogen lyase
Carbon-oxygen lyase	Carbon-oxygen lyase
Carbon-sulfur lyase	Carbon-sulfur lyase (substance)
Carboxy-lyase	Decarboxylase
Carboxylic ester hydrolase	Carboxylesterase
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe	Carmellose and hydroxyapatite only product in parenteral dose form
Carboxymethylcellulose sodium 16.58% oral paste	Carmellose 166 mg/g oromucosal paste
Carbuncle of head, except face	Carbuncle of head
Carbuncle of other specified site	Carbuncle of skin and/or subcutaneous tissue (disorder)
Carcinoid tumor no International Classification of Diseases for Oncology subtype	Malignant carcinoid tumor
Carcinoid tumor, argentaffin	Carcinoid tumor - argentaffin
Carcinoma in situ - category	Carcinoma in situ (morphologic abnormality)
Carcinoma in situ neoplastic process	Carcinoma in situ (morphologic abnormality)
Carcinoma in situ tumour	Carcinoma in situ (disorder)
Carcinoma in situ, no International Classification of Diseases for Oncology subtype	Carcinoma in situ (morphologic abnormality)
Carcinoma liver/biliary system NOS	Carcinoma liver and/or biliary system (disorder)
Carcinoma of cervix stage 0	Carcinoma in situ of uterine cervix
Carcinoma of skin (excluding eyelid, vulva, penis, and melanomas) TNM finding	American Joint Committee on Cancer allowable value
Carcinoma resembling breast carcinoma	Carcinoma (morphologic abnormality)
Carcinoma, no subtype	Carcinoma (morphologic abnormality)
Cardiac end diastolic volume, function (observable entity)	Cardiac end-diastolic volume (observable entity)
Cardiac glycoside adverse reaction	Adverse reaction to Digitalis glycoside
Cardiac status not worse than preoperative baseline	Cardiac status is consistent with or improved from preoperative baseline (finding)
Cardiomyopathy due to drugs and other external agents	Cardiomyopathy caused by drug
Cardiospasm	Achalasia of esophagus
cirrhose cardiotuberculeuse	Cirrhosis of liver
Care of Hickman catheter	Care of central venous catheter (regime/therapy)
Care of venous dissection	Procedure on cardiovascular system
plan de soins	Care plan (record artifact)
Care plan	Care plan (record artifact)
Care plan	Care plan (record artifact)
Cares for mentally handicapped dependent	Caregiver of dependent with intellectual disability
Carglumic acid 200mg dispersible tablet	Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug)
Carglutamic acid 200mg dispersible tablet	Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug)
Caring environment	Caring environment (finding)
Carlavirus group	Genus Carlavirus (organism)
Carmellose sodium 0.5% eye drops	Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Carmellose sodium 1% conventional release eye drops	Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug)
Carmellose sodium 1% single-use eye drops	Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug)
Carmustine 7.7mg wafer	Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug)
Carnobacterium piscicola	Carnobacterium maltaromaticum (organism)
Carotenosis cutis	Carotene pigmentation of skin

Start Previous Page 18 of 149 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)